Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
A novel polymer-conjugated human IL-15 improves efficacy of CD19-targeted CAR T-cell immunotherapy.
Journal: Blood advances
Published: August 02, 2022
Assessment and management of cytokine release syndrome and neurotoxicity following CD19 CAR-T cell therapy.
Journal: Expert opinion on biological therapy
Published: February 19, 2020
Insight into mechanisms associated with cytokine release syndrome and neurotoxicity after CD19 CAR-T cell immunotherapy.
Journal: Bone marrow transplantation
Published: August 22, 2019
Cell-intrinsic abrogation of TGF-β signaling delays but does not prevent dysfunction of self/tumor-specific CD8 T cells in a murine model of autochthonous prostate cancer.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: September 18, 2012
Showing 1-6 of 6
Last Updated: 09/26/2026